Leo Pharma appoints EVP for global product supply
27 February 2012 00:00 in Pharmaceutical Company Restructures
Leo Pharma has announced that Anders Spohr has been named executive vice-president (EVP) for global product supply.
Mr Spohr, who joined the pharmaceutical company in the role of senior vice-president in December 2011, assumes the new position on March 1st 2012 and takes responsibility for ensuring efficient and streamlined production processes worldwide.
He is taking over from John Mehlbye, who is retiring from the role but will still be on the Leo Foundation board moving forwards.
With qualifications in chemical engineering, biotechnology and business administration, Mr Spohr began his healthcare industry career at Novo Nordisk, before moving to Novozymes when the latter became an independent business.
He occupied a number of roles over an 11-year spell with the company, including that of vice-president for supply chain management.
Last month, Leo Pharma presented grants to a number of European life science business students as part of its annual BioBusiness and Innovation Programme.
Other news stories from 27/02/2012
Read more in the Zenopa News Archive
How this news is generated
Story collated for Zenopa by the Adfero News Agency